| ID | 1157 |
| Name of the vaccine | ProHIBiT |
| Microbe | Bacteria |
| Disease name | Haemophilus influenzae type b (Hib) |
| Name of bacteria | Haemophilus influenzae |
| Type of vaccine | Conjugate |
| Nucleic acid content | DNA |
| Age | 15 months and older |
| Description of the vaccine | Haemophilus b Conjugate Vaccine (Diphtheria Toxoid-Conjugate) (PRP-D). |
| Name of the manufacturer | Connaught |
| Name of the manufacturing country | NA |
| Year of manufacture | 1989 |
| Clinical Phase status | Approved |
| Bacterial strain | Anaerobic gram-negative coccobacillus. |
| Efficacy | 90% protective efficacy in children 18 to 71 months. |
| Vaccine formulation | Sterile solution |
| Dosage | Single injection of 0.5 mL. Primary immunization at 15 months of age or as Booster vaccination at 12 to 15 months. |
| Mechanism of action | Induces Anti-capsular antibodies. Antibody concentration of 0.15 µg/mL or more : Protection, 1 µg/mL or more : Long-term protection |
| Route of administration | Intramuscular |
| Indications | Immunization against invasive diseases caused by Haemophilus influenzae type b. |
| Export | ACIP |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | Diarrhoea, vomiting, crying, fever, irritability, sleepiness, anorexia, urticaria, seizure, and renal failure. |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NA |
| Reference | https://www.rxlist.com/prohibit-drug.htm#description |
| Other name | NA |
| Additional Links | https://www.immunize.org/timeline/
|